Two healthcare names are drawing fresh analyst attention this week as Wall Street recalibrates around a landmark GLP-1 truce and a fertility benefits company navigating a murky 2026 outlook. Barclays ...

As London is increasingly populated with hilariously tall buildings, we use our in-depth expert architectural nous to appraise the 100 loftiest of all. Note: We've also thrown in a handful of ...